These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 17850179)
1. BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. Cao W; Zhang L; Rosen DB; Bover L; Watanabe G; Bao M; Lanier LL; Liu YJ PLoS Biol; 2007 Sep; 5(10):e248. PubMed ID: 17850179 [TBL] [Abstract][Full Text] [Related]
2. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674 [TBL] [Abstract][Full Text] [Related]
3. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset. Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340 [TBL] [Abstract][Full Text] [Related]
11. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells. Florentin J; Aouar B; Dental C; Thumann C; Firaguay G; Gondois-Rey F; Soumelis V; Baumert TF; Nunès JA; Olive D; Hirsch I; Stranska R Blood; 2012 Nov; 120(23):4544-51. PubMed ID: 23053572 [TBL] [Abstract][Full Text] [Related]
12. Running to stand still: BCR-like signaling suppresses type I IFN responses in pDC. Swiecki MK; Colonna M Eur J Immunol; 2007 Dec; 37(12):3327-9. PubMed ID: 18050162 [TBL] [Abstract][Full Text] [Related]
13. CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCgamma2. Röck J; Schneider E; Grün JR; Grützkau A; Küppers R; Schmitz J; Winkels G Eur J Immunol; 2007 Dec; 37(12):3564-75. PubMed ID: 18022864 [TBL] [Abstract][Full Text] [Related]
14. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Tversky JR; Le TV; Bieneman AP; Chichester KL; Hamilton RG; Schroeder JT Clin Exp Allergy; 2008 May; 38(5):781-8. PubMed ID: 18318750 [TBL] [Abstract][Full Text] [Related]